Literature DB >> 3739631

Menstruation span--a time-limited risk factor for endometrial carcinoma.

B Pettersson, H O Adami, R Bergström, E D Johansson.   

Abstract

A case-control study was undertaken to investigate the influence of reproductive factors on the risk of developing endometrial carcinoma. The study comprised 254 women with newly diagnosed endometrial carcinoma, resident in a defined geographical area, and 254 age-matched population controls. Nulliparity and late menopause were positively associated with endometrial carcinoma. Each additional full-term pregnancy resulted in a decrease in the risk by 16%. The importance of parity and menopausal age decreased with increasing life span, and in women older than 69 years these two variables did not discriminate significantly between cases and controls. The calculated number of years of menstruation (the "menstruation span") was used as a combined measure of the impact of parity, age at menarche and age at menopause on the risk of developing endometrial carcinoma. The patients had a significantly longer mean menstruation span than the controls (33.6 versus 31.2 years; p less than 0.001) and a longer span than 39 years gave a 4.2 times higher risk than one shorter than 25 years. It is suggested that the total length of time for which a woman is exposed to unopposed estrogen is important and that the effect of this hormonal influence is time-limited.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739631     DOI: 10.3109/00016348609155179

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  13 in total

1.  Trends in endometrial cancer incidence and mortality in Sweden, 1960-84.

Authors:  I Persson; M Schmidt; H O Adami; R Bergstrøm; B Pettersson; P Sparén
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

2.  Timing of births and endometrial cancer risk in Swedish women.

Authors:  Ruth M Pfeiffer; Aya Mitani; Ola Landgren; Anders Ekbom; Sigurdur Y Kristinsson; Magnus Björkholm; Robert J Biggar; Louise A Brinton
Journal:  Cancer Causes Control       Date:  2009-06-30       Impact factor: 2.506

Review 3.  Carcinoma of the endometrium.

Authors:  B M Southcott
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Reproductive factors and incidence of endometrial cancer in U.S. black women.

Authors:  Todd R Sponholtz; Julie R Palmer; Lynn Rosenberg; Elizabeth E Hatch; Lucile L Adams-Campbell; Lauren A Wise
Journal:  Cancer Causes Control       Date:  2017-03-30       Impact factor: 2.506

5.  Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Authors:  Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen
Journal:  Am J Epidemiol       Date:  2016-04-15       Impact factor: 4.897

Review 6.  Early life circumstances and their impact on menarche and menopause.

Authors:  Gita D Mishra; Rachel Cooper; Sarah E Tom; Diana Kuh
Journal:  Womens Health (Lond)       Date:  2009-03

7.  Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA).

Authors:  L F Voigt; Q Deng; N S Weiss
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

Review 8.  A life course approach to reproductive health: theory and methods.

Authors:  Gita D Mishra; Rachel Cooper; Diana Kuh
Journal:  Maturitas       Date:  2010-01-15       Impact factor: 4.342

9.  On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study.

Authors:  H O Adami; U B Krusemo; L Bergkvist; I Persson; B Pettersson
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

10.  Reproductive risk factors for endometrial cancer among Polish women.

Authors:  L A Brinton; L C Sakoda; J Lissowska; M E Sherman; N Chatterjee; B Peplonska; N Szeszenia-Dabrowska; W Zatonski; M Garcia-Closas
Journal:  Br J Cancer       Date:  2007-04-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.